Study of biological therapy in patients with inflammatory bowel disease
Latest Information Update: 19 Dec 2022
At a glance
- Drugs Immunosuppressants (Primary) ; Tumour necrosis factor inhibitors (Primary) ; Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 01 Jan 2023 Results published in the European Journal of Gastroenterology and Hepatology
- 19 Dec 2022 New trial record